DCF — ASPIRUS MERRILL HOSPITAL
Enterprise Value: $31.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$31.2M
Enterprise Value
$8.5M
PV of Cash Flows
$22.7M
PV of Terminal Value
$36.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $27.5M | $3.7M | 14.0% | $1.8M | $1.6M |
| Year 2 | $28.4M | $4.1M | 15.0% | $2.1M | $1.7M |
| Year 3 | $29.2M | $4.5M | 16.0% | $2.4M | $1.8M |
| Year 4 | $30.1M | $4.8M | 16.0% | $2.5M | $1.7M |
| Year 5 | $31.0M | $5.1M | 16.0% | $2.7M | $1.7M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $31.2M. Terminal value accounts for 73% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$26.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.13060085827278772
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5